Early Access — free while we kick the tires
EdgarHawk

NXGL NEXGEL, INC. Insider Trading

11 filings analyzed · Latest 2024-11-22
Insider buys
11
Insider sells
0
Unique insiders
6
Direction
Net buying

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗

November 2024
2024-11-22
high
9,090 shares
$24,998
@ $2.75
Significance 6/10

Director Steven Mark Glassman buys 9,090 NXGL shares at $2.75; cluster of 5 other insiders bought within 14 days amid unprofitable fundamentals.

Director Steven Mark Glassman purchased 9,090 shares of NEXGEL, INC. at $2.75 on 2024-11-20, increasing his holdings to 154,155 shares (+6.3%). This transaction occurs within a cluster pattern: 5 other insiders also bought NXGL within the past 14 days, suggesting coordinated or reinforced confidence. However, the company context is challenging—the latest quarter showed Net income $-693,000.00 (negative) and the company remained unprofitable over its most recent full fiscal year, despite strong revenue growth of +99.7% year-over-year. Stock price momentum is favorable: the current price of $3.32 is +10.3% over 30 days and +27.7% over 90 days. Glassman's prior NXGL trades show mixed timing outcomes (2 of 4 prior buys well-timed at the 90-day mark), suggesting modest consistency but not a strong track record at this specific ticker.

2024-11-22
high
3,636 shares
$9,999
@ $2.75
Significance 6/10

Director Stein John Nachum bought 3,636 shares of NXGL at $2.75 on 2024-11-20; stock +10.3% in 30 days. Cluster pattern: 5 other insiders bought within 14 days.

Director John Nachum purchased 3,636 shares at $2.75, expanding his position to 471.5K shares (+0.8% from prior holdings). The purchase occurred amid positive near-term momentum: NXGL has gained 10.3% over 30 days and 27.7% over 90 days, well above its 52-week low of $1.76. His same-ticker history shows he has timed 3 of 4 prior buys well, with his August 2024 purchase delivering +9.6% in 30 days and +30.8% in 90 days. Most significantly, this buy is part of a broader cluster: 5 other insiders purchased within the past 14 days, suggesting coordinated conviction or response to a shared view. The company remains unprofitable (net income of $-693.0K in the latest quarter) but shows strong top-line momentum with annual revenue growth of +99.7%, creating a risk-reward dynamic where insiders are accumulating despite fundamental challenges.

2024-11-22
high
3,636 shares
$9,999
@ $2.75
Significance 6/10

Director Jerome Zeldis buys 3,636 shares of NXGL at $2.75 (Nov 20); 5 other insiders bought in past 14 days, cluster pattern amid unprofitable fundamentals.

Director Jerome Zeldis purchased 3,636 shares at $2.75 on 2024-11-20, increasing his holdings by +3.5% to 106,664 shares total. The purchase coincides with a cluster pattern: 5 other insiders also bought within the past 14 days, suggesting coordinated conviction or response to a company event. However, this must be weighed against deteriorating fundamentals—the company reported a net loss of $-693,000.00 against quarterly revenue of $2,940,000.00 and was unprofitable over its most recent full fiscal year, despite strong annual revenue growth of +99.7%. Zeldis's prior two purchases at NXGL generated mixed outcomes: the August 2024 buy showed +9.6% at 30 days and +30.8% at 90 days, but the May 2023 buy showed +13.8% at 30 days followed by -8.5% at 90 days, yielding a 50% success rate. The cluster activity and insider accumulation warrant attention given the unprofitability context.

2024-11-22
high
Chief Financial Officer
17,500 shares
$48,125
@ $2.75
Significance 6/10

CFO Adam E Drapczuk III purchases 17,500 NXGL shares at $2.75; cluster buy with 5 other insiders in 14 days

CFO Adam E Drapczuk III purchased 17,500 shares at $2.75 on 2024-11-20, increasing his holdings by 30.5% to 74,894 shares. This transaction is part of a cluster pattern with 5 other insiders also buying within the past 14 days, suggesting coordinated confidence at current valuation. His prior two trades at NXGL showed mixed timing results: the August 2024 buy generated +9.6% in 30 days and +30.8% in 90 days, while the March 2024 buy gained +29.4% in 30 days but declined -2.4% over 90 days, with only 1 of 2 prior buys at this ticker well-timed. The company remains unprofitable with net income of $-693,000.00 over the most recent quarter and negative full-year results, though annual revenue growth reached +99.7%, creating context of early-stage growth offset by cash burn.

2024-11-22
high
Chief Executive Officer
3,636 shares
$9,999
@ $2.75
Significance 7/10

CEO buys 3,636 shares at $2.75; 5 other insiders bought in past 14 days; unprofitable co. with 99.7% revenue growth

Adam R. Levy, Chief Executive Officer, purchased 3,636 shares at $2.75 on 2024-11-20, bringing his holdings to 333,196 shares. This buy coincides with a broader cluster pattern: 5 other insiders also purchased within the past 14 days. The company generated Revenue $2,940,000.00 in its latest quarter with Net income $-693,000.00, yet posted Annual revenue growth (FY vs prior FY) of +99.7%, indicating rapid expansion despite current unprofitability. The stock trades at $3.32, 30-day change +10.3%, and 90-day change +27.7%, suggesting recent positive momentum. The synchronized insider accumulation during a growth-phase expansion at a small-cap ($22,545,379.64 market cap) warrants investor attention to understand management's conviction and the company's path to profitability.

2024-11-22
high
1,818 shares
$5,000
@ $2.75
Significance 6/10

Director Henry Scott Robert bought 1,818 shares of NXGL at $2.75; stock up 10.3% in 30 days; 5 insiders buying within 14 days

Director Henry Scott Robert purchased 1,818 shares at $2.75 on 2024-11-20, increasing his holdings by +1.2% to 147,553 shares total. The stock has appreciated 10.3% over the past 30 days and 27.7% over 90 days, significantly outpacing the insider's cross-ticker average 30-day return of +10.1%. His same-ticker history at NXGL shows 3 of 5 prior buys delivered positive 90-day returns, indicating some pattern of successful timing in this stock. The filing reflects a cluster pattern with 5 other insiders also buying within the past 14 days. Context: NXGL remains unprofitable (full-year net income negative) despite strong annual revenue growth of +99.7%, and the current price of $3.32 is down 5.1% from its 52-week high of $3.50.

August 2024
2024-08-28
high
10,000 shares
$25,000
@ $2.50
Significance 6/10

Director Stein John Nachum buys 10,000 NXGL shares at $2.50; cluster of 4 insider purchases in 14 days amid unprofitable ops

Director Stein John Nachum purchased 10,000 shares (10.0K shares) at $2.50 on 2024-08-23, expanding his holdings from 461,820 to 471,820 shares. This transaction occurs within a broader pattern: 4 other insiders also bought within the past 14 days, signaling coordinated interest despite challenging fundamentals. NEXGEL is unprofitable (latest quarter net income: $-885,000.00; annual net income negative), though it posted strong revenue growth of +99.7% year-over-year. At the transaction price of $2.50, the stock has since declined to $2.85 (current), yet is down 4.7% over 30 days and -10.7% from its 52-week high of $3.19. Nachum's prior three purchases at NXGL showed mixed timing: 2 of 3 delivered positive 90-day returns, though the most recent prior buy on 2023-09-26 captured a +14.8% 90-day gain. The cluster buying pattern warrants attention as a potential forward-looking signal, but the company's path to profitability remains unclear given current operating losses.

2024-08-27
medium
10,000 shares
$25,000
@ $2.50
Significance 5/10

Director ZELDIS JEROME B bought 10,000 shares of NXGL at $2.50; stock at $2.71 is -15.0% from 52-week high; cluster of 4 other insiders buying in past 14 days

ZELDIS JEROME B (Director) purchased 10,000 shares at $2.50 on 2024-08-23, increasing holdings by +10.7% to 103,028 shares. The purchase occurs amid a coordinated cluster pattern—4 other insiders also bought within the past 14 days—which may reflect shared assessment of current valuation. The stock has declined -13.7% over 30 days and -15.0% from its 52-week high of $3.19, suggesting the purchase followed a recent pullback. However, fundamentals remain challenged: the company is unprofitable with net income of $-885,000.00 on revenue of $1,440,000.00 (latest quarter) and negative full-year net income, even as annual revenue growth was +99.7%. The director's prior buy at this ticker (2023-05-26) produced -8.5% returns over 90 days, and his cross-ticker track record shows a 0.00% 90-day win rate across 1 prior buy. The concurrent insider activity warrants attention to whether this reflects informed assessment or market momentum, particularly given the company's ongoing unprofitability.

2024-08-27
medium
Chief Financial Officer
10,000 shares
$25,000
@ $2.50
Significance 5/10

CFO Drapczuk buys 10,000 shares at $2.50; 4 other insiders bought within 14 days despite -13.7% 30-day price decline and unprofitable fundamentals.

Drapczuk Adam E III, Chief Financial Officer, purchased 10,000 shares at $2.50 on 2024-08-23, increasing his holdings by 21.1% to 57,394 shares total. The buy occurred within a 14-day window in which 4 other insiders also purchased shares, constituting a cluster pattern. However, this coordinated buying activity took place against a backdrop of significant price weakness: the stock has declined 13.7% over 30 days and is trading 15.0% below its 52-week high of $3.19. More importantly, the company reported quarterly revenue of $1,440,000.00 with a net loss of $885,000.00 and remained unprofitable over its full fiscal year, despite posting annual revenue growth of +99.7%. The timing and intensity of insider purchases warrant investor scrutiny, as they may reflect insider assessment of value following a sharp price decline, but the unprofitable operational state limits the strength of any positive signal.

2024-08-27
high
10,000 shares
$25,000
@ $2.50
Significance 6/10

Director Henry Scott Robert bought 10,000 shares of NXGL at $2.50; stock down 13.7% in 30 days as 4 other insiders also bought in 14-day cluster.

Director Henry Scott Robert purchased 10,000 shares of NEXGEL, INC. at $2.50 on 2024-08-23, increasing his holdings by 7.4% to 145,735 shares total. The purchase occurs within a cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated confidence. However, the stock has declined 13.7% over the past 30 days and is currently 15.0% below its 52-week high of $3.19, indicating headwinds since the transaction. At NXGL specifically, Robert's prior timing record is mixed—only 2 of his 5 prior buys at this ticker showed positive 90-day returns. Fundamentally, NEXGEL reported $1.4M revenue in its latest quarter but remains unprofitable with net income of $-885.0K, though it shows annual revenue growth of +99.7%, warranting investor attention to whether this growth trajectory can ultimately drive profitability.

Insiders here also file at

More Measuring and Controlling Instruments companies

Get alerts for NXGL

Add NXGL to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access